Evidence map›Paper›PMID 26582057›Full record

ArticleBMC cancer2015

Prostate specific G protein coupled receptor is associated with prostate cancer prognosis and affects cancer cell proliferation and invasion.

Wenqing Cao, Faqian Li, Jorge Yao, Jiangzhou Yu

Open access · goldAbstract read
In one paragraph

Article in BMC cancer, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 13 papers.

0numbers the graph read from it
0cells of the map it votes in
13citing papers in PubMed
2.2field-weighted citation impact, top 12% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

13 citing papers in PubMed, 32 citations in OpenAlex.

  1. Trial
  2. Olfactory receptors and human diseases.Cell and tissue research · 2025
    Review
  3. Article
  4. Article
  5. Article
  6. Odorant receptors in cancer.BMB reports · 2022
    Review
  7. Article
  8. Ionone Is More than a Violet's Fragrance: A Review.Molecules (Basel, Switzerland) · 2020
    Review
  9. Review
  10. Review
  11. Review
  12. Article
  13. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Wenqing CaoDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA. wenqing.cao@nyumc.org.
Faqian LiDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA. lif@umn.edu.
Jorge YaoDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA. JYao@pathlinelabs.com.
Jiangzhou YuDepartment of Pathology and Laboratory Medicine, University of Rochester Medical Center, Rochester, NY, USA. jiangzhou8888@gmail.com.
University of Rochester Medical Center · US

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

backgroundThere is limited information about the clinical and biological significance of prostate specific G protein coupled receptor (PSGR) in prostate cancer (PCa) initiation and progression. Here, we evaluated the expression of PSGR protein, studied its diagnostic and prognostic value in PCa, and also explored its role in cancer cell growth and invasion.

methodsThe expression of PSGR in paired adjacent normal prostate, high grade prostatic intraepithelial neoplasia (PIN), and PCa were determined by immunohistochemistry on tissue microarrays constructed from 150 radical prostatectomy specimens. The effects of PSGR on PCa cell growth and invasion were investigated using human PCa cell lines.

resultsMembranous and cytoplasmic PSGR staining was observed at luminal epithelial cells of prostate. PSGR protein expression was significantly higher in PIN compared to normal prostate. Interestingly, the expression of PSGR decreased as PIN progressed to PCa. Low PSGR expression in PCa was associated with high Gleason score, and poor overall survival. Activated PSGR increased cancer cell invasive ability, but retarded cell growth. PSGR did not affect mTOR activity, but suppressed P70 S6 kinase activity.

conclusionsPSGR may participate in PCa progression through affecting cell proliferation and invasion. High expression of PSGR in PIN may implicate its role in early neoplastic transformation of PCa. Low expression of PSGR in PCa may serve as a potential indicator for poor prognosis.

Indexed as

Cell ProliferationAdultAgedBiomarkers, TumorCell MembraneCytoplasmHumansImmunohistochemistryMaleMiddle AgedNeoplasm GradingNeoplasm InvasivenessPrognosisProstatic Intraepithelial NeoplasiaProstatic NeoplasmsReceptors, G-Protein-CoupledBiomarkers, TumorReceptors, G-Protein-Coupled

Identifiers

PMID26582057
PMCPMC4652354
OpenAlexW2173698125

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.